CARMUSTINE
≥98 %
science Other reagents with same CAS 154-93-8
blur_circular Chemical Specifications
description Product Description
Used primarily in chemotherapy to treat certain types of brain tumors, such as glioblastoma multiforme and medulloblastoma. It is also effective in treating multiple myeloma and lymphoma. Administered intravenously or as a wafer implanted directly into the brain after tumor removal, it works by inhibiting DNA and RNA synthesis, thereby preventing cancer cell growth. Additionally, it is sometimes used topically for certain skin lymphomas, such as mycosis fungoides, or in combination with other drugs to enhance its therapeutic effects. Due to its potent nature, careful monitoring is required to manage potential side effects, including bone marrow suppression and lung toxicity.
format_list_bulleted Product Specification
| Test Parameter | Specification |
|---|---|
| Appearance | Light yellow to yellow powder, solid or oily liquid |
| Purity | 98-100 |
| Proton NMR Spectrum | Conforms to Structure |
| Infrared Spectrum | Conforms to Structure |
| Solubility in Ethanol | Pale Yellow to Yellow Clear (19.60-20.40 mg/ml) |
| Note | Low melting point solid; may change state in different environments (solid, liquid, or semi-solid) |
shopping_cart Available Sizes & Pricing
Cart
No products